Table 2.
Patient Characteristics
Variable | N = 60 (100%) |
---|---|
Age | |
Median | 59 years |
Range | 29 to 70 years |
Gender | |
Male | 42 (70%) |
Female | 18 (30% |
Race/Ethnicity | |
Asian | 1 (1.7%) |
Black | 2 (3.3%) |
Hispanic | 10 (17%) |
Other | 3 (5.0%) |
White | 43 (72%) |
KPS at baseline | |
70 | 14 (23%) |
80 | 17 (28%) |
90 | 25 (42%) |
100 | 4 (7%) |
MGMT promoter status | |
Methylated | 20 (33%) |
Unmethylated | 39 (65%) |
Equivocal | 1 (2%) |
IDH1/2 genes | |
Mutated | 7 (12%) |
Not Mutated | 53 (88%) |
Anatomic Location of Tumor | |
Frontal | Left 11 (18%), Right 5 (8.3%) |
Parietal | Left 6 (10%), Right 8 (13%) |
Temporal | Left 7 (12%), Right 13 (22%) |
Occipital | Left 2 (3.3%), Right 1 (1.7%) |
Fronto-Temporal | Left 0 (0%), Right 1 (1.7%) |
Parieto-Occipital | Left 1 (1.7%) Right 0 (0%) |
Temporo-Occipital | Left 0 (0%) Right 1 (1.7%) |
Temporo-parieto-occipital | Left 1 (1.7%), Right 0 (0%) |
Temporal and Amygdala | Left 0 (0%), Right 1 (1.7%) |
Insula | Left 1 (1.7%), Right 0 (0%) |
Corpus callosum | Left 1 (1.7%), Right 0 (0%) |